Malignant Neoplasm of Lung - Multiple Primary Sites

Malignant Neoplasm of Lung - Multiple Primary Sites — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04840758	Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer	unknown	Phase 1 / Phase 2	39	The First Affiliated Hospital of Xiamen UniversityOTHER	0	Apr 12, 2021	clinicaltrials

Data updated 22 days agoSource updated Apr 12, 2021source: clinicaltrials